American Journal of Roentgenology, Vol 157, 721-725, Copyright © 1991 by American Roentgen Ray Society

ARTICLES

Value of dual-energy CT in differentiating focal fatty infiltration of the liver from low-density masses

V Raptopoulos, A Karellas, J Bernstein, FR Reale, C Constantinou and JK Zawacki
Department of Radiology, University of Massachusetts Medical Center, Worcester 01655.

Focal (irregular, partial) fatty infiltration of the liver may simulate neoplastic or other hypodense masses on CT. On the basis of previous observations of the phenomenon that differences in X-ray attenuation diminish with increasing energy of X-rays used, we performed a preliminary study to determine if dual-energy CT could be used to discriminate between fatty infiltration and hypodense liver masses. Dual-energy CT at 140 and 80 kVp was performed in 14 patients undergoing liver biopsy and in seven control subjects with presumedly normal liver. Attenuation measurements were taken, and the changes in attenuation between 140 and 80 kVp were calculated. The mean changes in attenuation were 3.5 H for normal liver (n = 7), 2.5 H for hypodense liver masses (n = 6), 13 H for fatty liver (n = 5), 0.3 H for fatty liver combined with hemochromatosis or hemosiderosis (n = 3), and 2 H for the spleen (n = 18). The change in attenuation increased as the fat content in the liver increased. Analysis of variance showed a statistically significant difference (p less than .001) between fatty liver and the other groups. A difference greater than 10 H was unique to fatty infiltration. These results suggest that dual-energy CT may help to differentiate focal fatty infiltration of the liver from low- density neoplastic or other lesions, but only if the iron content of the liver is not increased.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. G. Lall, A. M. Aisen, N. Bansal, and K. Sandrasegaran Nonalcoholic Fatty Liver Disease Am. J. Roentgenol., April 1, 2008; 190(4): 993 - 1002. [Abstract] [Full Text] [PDF]

				J. H. Lee, J. L. Chan, E. Sourlas, V. Raptopoulos, and C. S. Mantzoros Recombinant Methionyl Human Leptin Therapy in Replacement Doses Improves Insulin Resistance and Metabolic Profile in Patients with Lipoatrophy and Metabolic Syndrome Induced by the Highly Active Antiretroviral Therapy J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2605 - 2611. [Abstract] [Full Text] [PDF]

				P. Limanond, S. S. Raman, C. Lassman, J. Sayre, R. M. Ghobrial, R. W. Busuttil, S. Saab, and D. S. K. Lu Macrovesicular Hepatic Steatosis in Living Related Liver Donors: Correlation between CT and Histologic Findings Radiology, January 1, 2004; 230(1): 276 - 280. [Abstract] [Full Text] [PDF]

				N. Erbay, V. Raptopoulos, E. A. Pomfret, I. R. Kamel, and J. B. Kruskal Living Donor Liver Transplantation in Adults: Vascular Variants Important in Surgical Planning for Donors and Recipients Am. J. Roentgenol., July 1, 2003; 181(1): 109 - 114. [Abstract] [Full Text] [PDF]

				I. R. Kamel, J. B. Kruskal, E. A. Pomfret, M. T. Keogan, G. Warmbrand, and V. Raptopoulos Impact of Multidetector CT on Donor Selection and Surgical Planning Before Living Adult Right Lobe Liver Transplantation Am. J. Roentgenol., January 1, 2001; 176(1): 193 - 200. [Abstract] [Full Text]

				I. R. Kamel, V. Raptopoulos, E. A. Pomfret, J. B. Kruskal, R. A. Kane, C.-S. Yam, and R. L. Jenkins Living Adult Right Lobe Liver Transplantation: Imaging Before Surgery with Multidetector Multiphase CT Am. J. Roentgenol., October 1, 2000; 175(4): 1141 - 1143. [Full Text] [PDF]